SUDA Pharmaceuticals (ASX:SUD) Presentation, FNN Investor Event, September 2019, Sydney

Company Presentations

SUDA Pharmaceuticals Limited (ASX:SUD) Managing Director and CEO, Stephen Carter presents on the company's portfolio and the benefits of reformulating and delivering medication through the oral mucosa at FNN's Investor Event.

Key points:

  • World leader in reformulating and delivering medication through oral spray
  • Has increased bioavailability up to 95 per cent
  • This is a major step forward in the evolution of drug delivery technology
  • Faster, potentially smaller doses & safer delivery for ex-blockbuster drugs
  • Technology validated with licensing deals with Teva and Mitsubishi
  • Robust intellectual property portfolio with over 50 patents

For more, watch Managing Director and CEO Stephen Carter present.